HopeStage
Back to all studies
TerminatedNCT01520350

Low-Dose Adjunctive Aripiprazole in the Treatment of Depression in bipolarity: Double-Blind Placebo-Controlled Pilot Study

Medication studyAges 18–65Canada
The study in practice

Understand this study

Who could participate?

This study is for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Listed locations
MontrealSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateFebruary 2012
Recruitment status
Terminated
Enrollment listed in the registry
2
Sponsor
Serge Beaulieu
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Canada
Age range
From 18 Years to 65 Years
Official registry ID
NCT01520350
Official title
Show the full official title

Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study

Recruitment & locations

Terminated

Montreal

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Serge Beaulieu.

Does this study involve medication?

Yes. The study involves medication, including Low dose Adjunctive Aripiprazole and placebo.

Who can participate?

This study is for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies